πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 169 of 200 Β· A–Z by INN

  1. sodium fluoride

    COLGATE TOTAL

    DENTAL FDA: approved

  2. sodium fluoride f-18

    SODIUM FLUORIDE F-18 Chongqing Precision Biotech Co., Ltd

    INTRAVENOUS FDA: approved

  3. sodium iodide i-123

    SODIUM IODIDE I 123

    ORAL FDA: approved

  4. sodium iodide i-131

    SODIUM IODIDE I 131 Praxis Precision Medicines

    ORAL FDA: approved

  5. sodium lactate

    SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER

    INJECTION FDA: approved

  6. sodium monofluorophosphate

    EXTRA-STRENGTH AIM

    DENTAL FDA: approved

  7. sodium nitrite

    NITHIODOTE

    INTRAVENOUS, INTRAVENOUS FDA: approved

  8. sodium nitroprusside

    SODIUM NITROPRUSSIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  9. sodium oxybate

    XYREM Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: approved

    N07XX04
  10. sodium phenylbutyrate

    PHEBURANE Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    A16AX03
  11. sodium phosphate p-32

    SODIUM PHOSPHATE P 32

    INJECTION, ORAL FDA: approved

  12. sodium phosphate, dibasic, anhydrous

    MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

    ORAL FDA: approved

  13. sodium phosphate, dibasic, heptahydrate

    SODIUM PHOSPHATES IN PLASTIC CONTAINER Regeneron Ireland Designated Activity Company (DAC)

    INTRAVENOUS FDA: approved

  14. sodium polystyrene sulfonate

    RESONIUM-A Sanofi-aventis Healthcare Pty Ltd

    ORAL, RECTAL FDA: approved Β· TGA: approved

  15. sodium succinate

    SODIUM SUCCINATE

    INJECTION FDA: approved

  16. sodium tetradecyl sulfate

    SOTRADECOL

    INJECTION FDA: approved

  17. sodium thiosulfate

    PEDMARQSI FENNEC PHARMACEUTICALS INC.

    INJECTION FDA: approved Β· EMA: approved

  18. sodium thiosulfate (use as additive only)

    NULL

    TGA: approved

  19. sodium zirconium cyclosilicate

    LOKELMA

    ORAL FDA: approved Β· EMA: approved

    V03AE10
  20. sofosbuvir

    EPCLUSA Teva Pharma GmbH

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    J05AX15
  21. sofosbuvir + velpatasvir

    EPCLUSA Gilead Sciences Pty Limited

    TGA: approved

  22. sofosbuvir + velpatasvir + voxilaprevir

    VOSEVI Gilead Sciences Pty Limited

    TGA: approved

  23. sofpironium bromide

    SOFDRA

    TOPICAL FDA: approved

  24. solifenacin succinate

    SOLIFENACIN SUCCINATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources